News

We invest in growth stage diagnostic companies and empower them with the full strength of our collective resources, capital, and expertise.

Sapphiros Appoints Healthcare Executive Jackson McAdam as Chief Financial Officer

READ MORE

Sapphiros Launches NowFuture™: A New Era in Personalized Wellness

READ MORE

Sapphiros Is Pleased To Announce OraSure Technologies, Inc. Secures Strategic Distribution Rights and Invests In Sapphiros

READ MORE

Sapphiros and Cencora, formerly AmerisourceBergen Corporation, Enter into Distribution Agreement

READ MORE

Satio Receives Funding From ARPA-H to Develop SatioRx™ a Novel At-home, Remotely Controllable Transdermal Drug Delivery Device

READ MORE

Satio Partners with BARDA DRIVe to Develop a Novel Patch-based Ebolavirus Diagnostic

READ MORE